Table 2.
Final diagnoses in 28 patients with negative RASopathy next-generation sequencing test results
| Final diagnosis |
|---|
| Cytogenetic disorders |
| Unbalanced translocation: 46,XY,der(9)t(2;9)(q34;p23) |
| 7.01 Mb terminal deletion on chromosome 11q24.3q25, Jacobsen syndrome |
| 4.23 Mb deletion of 4p16.3, Wolff-Hirschhorn syndrome |
| 2.73 Mb duplication of 1q21.1q21.2 |
| 1.74 Mb duplication of 1q21.3q22 |
| 22q11.2 duplication (A to D region) |
| 313 kb deletion of 8q24.3 |
| 411 kb duplication of 16q24.1 |
| 1.92 Mb duplication of 15q26.1 |
| 62.9 Mb maternal uniparental isodisomy 20p13q13.33 |
| Single-gene disorders |
| IFT122 p.A446V homo, cranioectodermal dysplasia type I |
| ARID1B p.G351AfsX12 het, Coffin-Siris syndrome |
| MRPS22 p.R170H; p.G257KfsX3 comp het, combined oxidative phosphorylation deficiency 5 |
| GHR p.R179C het, paternally inherited, GHR |
| FERMT3 p.R573* homo, leukocyte adhesion deficiency |
| SLC25A3 p.L200W, p.G296_S300delinsQIF compound het, mitochondrial phosphate carrier deficiency |
| NF1 p.K1423G het, neurofibromatosis with Noonan syndrome–like features |
| FZD6 p.R116* and p.C461R compound het, disease-candidate gene |
| IDUA p.Q70* homo, mucopolysaccharidosis type I |
| NEBL p.S539* het, dilated cardiomyopathy |
| PEX12 c.888_889del CT and c.894delC compound het, peroxisome biogenesis disorder 3A (Zellweger) |
| RBM10 p.M415L hemi, de novo TARP syndrome |
| BZRAP1 p.R1375* and p.R215G compound het, disease-candidate gene |
| KMT2A p.S2110* het, de novo Wiedemann–Steiner syndrome |
| Clinically diagnosed syndromes |
| Beckwith–Wiedemann syndrome and probably an additional undiagnosed syndrome |
| Ehlers–Danlos syndrome |
| Segmental neurofibromatosis type I |
| Jeune syndrome |
Neurofibromatosis type I was found in two patients; all other diagnoses found were in one patient each.
TARP syndrome: talipes equinovarus, atrial septal defect, Robin sequence, and persistence of the left superior vena cava.